Friday's top analyst upgrades and downgrades included Amgen, CarMax, D.R. Horton, Frontier, General Electric, Home Depot, Ingersoll Rand, Marathon Digital, MetLife, Palantir...
Friday's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Accenture, Amgen, AutoZone, Azek, Boeing, Dollar General, Etsy, Fidelity National Information...
By Nancy Lapid (Reuters) – The following are summaries of some of the cancer research advances being presented the annual meeting of the American Society of Clinical Oncology...
Wall Street finished last week awash in red as US CPI increased more quickly than expected in May, accelerating the debate as to how much the Federal Reserve will raise interest...
The COVID-19 pandemic highlighted the importance of health care and the role biopharma companies play in drug and vaccine development. As a result, the sector grew tremendously...
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Sell | Neutral | Buy |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Sell | Strong Buy |
| Summary | Neutral | Strong Sell | Strong Sell | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 19.53 | 20.10 | 18.67 | +0.120 | +0.62% | 210.09K | Toronto | |||
| 28.53 | 28.63 | 28.33 | -0.04 | -0.14% | 723.13K | Toronto | |||
| 13.65 | 13.65 | 13.59 | -0.02 | -0.15% | 620.00 | Toronto | |||
| 71.34 | 73.50 | 70.69 | -0.49 | -0.68% | 2.33M | Toronto | |||
| 12.42 | 12.65 | 11.94 | +0.28 | +2.31% | 54.61K | Toronto | |||
| 31.18 | 32.14 | 31.14 | -0.62 | -1.95% | 237.05K | Toronto | |||
| 115.75 | 116.33 | 113.08 | +1.74 | +1.53% | 173.57K | Toronto | |||
| 123.73 | 125.21 | 123.69 | -0.95 | -0.76% | 419.97K | Toronto | |||
| 63.23 | 63.49 | 62.99 | +0.15 | +0.24% | 440.88K | Toronto | |||
| 19.12 | 19.20 | 18.71 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 74.61 | 75.30 | 74.51 | -0.41 | -0.54% | 337.33K | Toronto | |||
| 41.73 | 42.67 | 41.56 | -0.63 | -1.49% | 16.30K | Toronto | |||
| 1.57 | 1.58 | 1.57 | 0.000 | 0.00% | 13.10K | CSE | |||
| 0.18 | 0.18 | 0.18 | 0.00 | 0.00% | 0.00 | TSXV | |||
| 1.27 | 1.27 | 1.25 | +0.010 | +0.79% | 2.10K | CSE |